Sexual transmission was suspected in around 90% of transgender women patients but only in 61% of cisgender women and non-binary patients.
Academic rigor, journalistic flair
Articles on Monkeypox vaccine
Displaying all articles
Public health measures have played a big role in curbing the current outbreak.
The hoarding of the COVID-19 vaccine by wealthy nations led to global calls for vaccine equity. Unless wealthy nations commit to change, the monkeypox vaccine rollout could meet a similar fate.
Engaging in open and honest dialogue with the public to increase understanding of health inequities has never been more important.
Countries have to weigh up the cost of vaccinating everybody versus the cost of treating the disease.
Chronic weaknesses in our global vaccine manufacturing and distribution systems may broadly be to blame.
Some of the sexual moralising we saw with HIV is still with us. That makes it harder for men who have sex with men to come forward for vaccines and testing.
The right public health measures can be very effective at curbing the virus’s spread – if executed properly.
Declaring monkeypox a national health emergency will allow the U.S. government to direct resources and funds where needed to help slow the spread of the virus.
There are two approved monkeypox vaccines in the US. Both use a related poxvirus called vaccinia to produce an immune response that protects against smallpox and monkeypox.
The third-generation vaccine has fewer potential side effects than second-generation vaccines and can be safely given to people with weakened immune systems.
Top contributors
-
Associate Professor in Public Health, La Trobe University
-
Associate Professor and Principal Research Fellow at the Australian Research Centre in Sex, Health and Society, La Trobe University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Public Health, University of Sheffield
-
Director, Biopharming Research Unit; and Member, Institute of infectious Disease and Molecular Medicine, University of Cape Town
-
Associate Professor of Biology, Rochester Institute of Technology
-
Associate Professor in Biomedical Technology, University of Southampton
-
Professor in Vaccinology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Senior Lecturer, Biomedical Science, Birmingham City University
-
Assistant Professor in Health Sciences, Faculty of Health Sciences, Simon Fraser University
-
William E. Cooper Distinguished University Chair, Professor of Health Studies, University of Richmond
-
Chair Professor of HIV Medicine, Queen Mary University of London
